GB1125410A - Pharmaceutical compositions containing sulphones - Google Patents
Pharmaceutical compositions containing sulphonesInfo
- Publication number
- GB1125410A GB1125410A GB3380366A GB3380366A GB1125410A GB 1125410 A GB1125410 A GB 1125410A GB 3380366 A GB3380366 A GB 3380366A GB 3380366 A GB3380366 A GB 3380366A GB 1125410 A GB1125410 A GB 1125410A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulphones
- compositions
- penetrant
- compositions containing
- properties
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
- C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,125,410. Compositions containing sulphones. MERCK & CO. Inc. 27 July, 1966 [2 Aug., 1965], No. 33803/66. Headings A5B and A5E. [Also in Division D2] Pharmaceutical and biocidal compositions comprise hydroxy-aliphatic sulphones or their acyl esters, of formula: or their cyclic acetals, of formula: wherein each of R and R<SP>1</SP> is a cycloaliphatic group, or an aliphatic group or R and R<SP>1</SP> together are an alkylene group of at least 3 carbons forming a heterocycle with the sulphur atom, R<SP>1</SP> in the acetals having at least 2 adjacent carbons to which are attached the oxygen atoms; X<SP>1</SP> is hydrogen or an acyl radical, R<SP>2</SP> and R<SP>3</SP> are each alkyl, and n and n' are each 0-2, with n + n' being 1 or 2; together with an inert carrier diluent or coating, which, if other than a solid or an oil, includes one or more sweetening, flavouring, colouring, preserving, suspending or wetting agents; optionally together with other active ingredients. The pharmaceutical compositions may be in forms suitable for oral, parenteral or topical application, and may take the form of tablets, aqueous or oily suspensions, dispersible powders or granules, emulsions, hard or soft capsules, syrups or elixirs, skin penetrant ointments, creams, lotions, or sprays, and mucosally absorbed forms such as suppositories and nasal compositions. The sulphones have tissue penetrant properties and may be included in compositions containing other, non-penetrant active agents, to promote absorption of the latter. Preferred such compositions are anti-perspirant creams, lotions, emulsions, powders or self-propelled aerosols, wherein the further active agent is a metal salt astringent such as zirconium lactate, zinc phenol sulphonate, or an aluminium salt such as the chloride-hydrate, hydroxidedichloride-hydrate, phosphate, sulphonate, or phenolsulphonate. The sulphones have anti-inflamatory activity including analgesic and anti-pyretic properties, and they also relieve respiratory congestion; additionally they have muscle relaxant, microbicidal, (including fungi and viruses), and diuretic properties, and have application in the treatment of burns and circulatory deficiencies and to promote the healing of skin grafts. The invention includes a method for treating animals to relieve pain, fever and inflammation, comprising administering the sulphone. Biocidal compositions of the active sulphones are useful for freeing a non-human locus from micro-organisms, including bacteria, fungi and viruses, and they may be employed as industrial slimicides in re-cycled water, used in air-conditioning units, or the textile or chemical industries.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27669565A | 1965-08-02 | 1965-08-02 | |
US47669565A | 1965-08-02 | 1965-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1125410A true GB1125410A (en) | 1968-08-28 |
Family
ID=26958085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3380366A Expired GB1125410A (en) | 1965-08-02 | 1966-07-27 | Pharmaceutical compositions containing sulphones |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE684959A (en) |
FR (2) | FR5699M (en) |
GB (1) | GB1125410A (en) |
IL (1) | IL26209A (en) |
NL (1) | NL6610879A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2464069A1 (en) * | 1979-08-30 | 1981-03-06 | Herschler Robert | METHYLSULFONYLMETHANE-BASED COMPOSITIONS, PROCESS FOR PURIFICATION THEREOF AND USES THEREOF IN PARTICULAR THERAPEUTIC |
EP0103836A2 (en) * | 1982-09-14 | 1984-03-28 | Robert J. Herschler | Dietary and pharmaceutical compositions comprising methylsulfonylmethane |
USRE41151E1 (en) | 2000-06-23 | 2010-02-23 | Medinox, Inc. | Protected forms of pharmacologically active agents and uses thereof |
US10441555B2 (en) | 2012-06-11 | 2019-10-15 | Olatec Therapeutics Llc | Pharmaceutical composition |
-
1966
- 1966-07-25 IL IL2620966A patent/IL26209A/en unknown
- 1966-07-27 GB GB3380366A patent/GB1125410A/en not_active Expired
- 1966-08-01 FR FR71682A patent/FR5699M/fr not_active Expired
- 1966-08-02 NL NL6610879A patent/NL6610879A/xx unknown
- 1966-08-02 BE BE684959D patent/BE684959A/xx unknown
- 1966-10-29 FR FR82109A patent/FR1505491A/en not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2464069A1 (en) * | 1979-08-30 | 1981-03-06 | Herschler Robert | METHYLSULFONYLMETHANE-BASED COMPOSITIONS, PROCESS FOR PURIFICATION THEREOF AND USES THEREOF IN PARTICULAR THERAPEUTIC |
EP0103836A2 (en) * | 1982-09-14 | 1984-03-28 | Robert J. Herschler | Dietary and pharmaceutical compositions comprising methylsulfonylmethane |
EP0103836A3 (en) * | 1982-09-14 | 1986-07-30 | Robert J. Herschler | Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it |
USRE41151E1 (en) | 2000-06-23 | 2010-02-23 | Medinox, Inc. | Protected forms of pharmacologically active agents and uses thereof |
US10441555B2 (en) | 2012-06-11 | 2019-10-15 | Olatec Therapeutics Llc | Pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
FR5699M (en) | 1968-01-15 |
NL6610879A (en) | 1967-02-03 |
BE684959A (en) | 1967-02-02 |
FR1505491A (en) | 1967-12-15 |
IL26209A (en) | 1970-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4424232A (en) | Treatment of herpes simplex | |
KR880000091A (en) | Topical Pharmaceutical Compositions Method of Preparation and Use thereof | |
EP0380157B1 (en) | Wound healing powder | |
ES8702784A1 (en) | Hair care compositions. | |
DE69432208D1 (en) | Preparation for the treatment of acne, seborrheic dermatitis and other skin diseases | |
DE69308969T2 (en) | Antiperspirant agents and composition containing titanium salt | |
KR930702954A (en) | Composition | |
Heck et al. | Aloe vera (gel) cream as a topical treatment for outpatient burns | |
GB1125409A (en) | Pharmaceutical compositions containing sulphoxides | |
GB1125410A (en) | Pharmaceutical compositions containing sulphones | |
KR920700627A (en) | Novel use of 1-phenyl-2-aminoethanol derivatives as therapeutic agents | |
NO822681L (en) | WATER DILABLE PREPARATION WITH BACTERICIDE AND FUNGICIDE EFFECTS | |
IL107614A0 (en) | Vitamin d3 analogs their preparation and pharmaceutical compositions containing them | |
Thakur et al. | Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? | |
EP0999819B1 (en) | Physiological combination of active substances to enhance the skin's defenses against noxious agents | |
ES2000681A6 (en) | Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use. | |
DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
US3452139A (en) | Method of treating seborrheic dermatitis with n,n-diethyl-m-toluamide | |
SE8404560L (en) | CLEAN UP COMPOSITION | |
KR880013563A (en) | Pharmaceutical, Veterinary and Cosmetic Uses of Hydroxyalkylphosphine Compounds | |
US3904765A (en) | Process for controlling lamellar dystrophy of fingernails | |
KR950703528A (en) | Prostaglandin E₁Flexible | |
JPS5636410A (en) | Ointment for treating athlete's foot | |
JPH02169501A (en) | Control of formaldehyde | |
Moore | Glasshouse experiments on apple scab: III. Fungicide mixtures, curative translocation, and the influence of mildew |